Business Context and Reporting Period
This Form 8-K reports on the results of ProKidney Corp.'s 2025 Annual General Meeting of Shareholders held on May 29, 2025. The filing details shareholder votes on corporate governance matters, including a jurisdictional change from the Cayman Islands to Delaware.
Key Financial Metrics
This filing is a Current Report regarding shareholder voting results and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
Shareholders approved several material proposals by special or ordinary resolution:
- Domestication Proposal: Approved the change of incorporation from the Cayman Islands to the State of Delaware (227,587,563 For vs. 1,119,814 Against).
- New Charter Proposal: Approved the adoption of a new certificate of incorporation for the post-domestication entity (226,735,353 For vs. 1,970,901 Against).
- Advisory Charter Proposals: Shareholders approved five advisory proposals (A through E) regarding exclusive forum provisions, renunciation of corporate opportunities, capital stock adjustments, removal of written resolution rights, and supermajority voting requirements for bylaw and charter amendments.
- Election of Directors: Bruce Culleton, M.D., Pablo Legorreta, and Uma Sinha, Ph.D., were elected to the Board for three-year terms.
- Auditor Ratification: Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
Guidance, Outlook, and Risks
Management expects to complete the Domestication process by the end of the third quarter of 2025. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ due to risks such as economic conditions and the finalization of quarter-end results. No specific financial guidance or unusual items were disclosed in this report.
Investor Verification Checklist
- Verify the effective date of the Domestication and the subsequent filing of the new Certificate of Incorporation in Delaware.
- Confirm the updated authorized share capital structure (700,000,000 Class A, 500,000,000 Class B, and 50,000,000 preferred shares) post-domestication.
- Review the new bylaws and charter provisions regarding exclusive forum selection and supermajority voting thresholds.
- Monitor the company's next quarterly report for the first financial results under the Delaware corporate structure.